AstraZeneca PLC - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
AZN New York 2834 www.astrazeneca.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for AstraZeneca PLC

AstraZeneca’s cancer pipeline posts two wins and a loss - Sep 14th, 2026 10:46 am
AZN's Etcamah Fails Late-Stage Study for First-line Breast Cancer - Sep 14th, 2026 10:08 am
Can Pfizer Overcome Its COVID and Patent Cliff Headwinds? - Sep 14th, 2026 7:37 am
Sector Update: Healthcare Stocks Rise Premarket Monday - Sep 14th, 2026 7:17 am
Coultreon Biopharma Appoints Nate Massari as Chief Business Officer - Sep 14th, 2026 7:00 am
Why Is AstraZeneca Stock Trading Higher Today? - Sep 14th, 2026 6:46 am
AstraZeneca’s newly approved pill fails frontline breast cancer study - Sep 14th, 2026 6:30 am
Olema Pharmaceuticals Shares Fall 15.1% Following AstraZeneca SERENA-4 Trial Results - Sep 14th, 2026 6:10 am
AstraZeneca breast cancer drug fails trial but Citi keeps 'buy' rating - Sep 14th, 2026 6:01 am
Big Pharma Is Pouring Billions Into China’s Biotechs - Sep 14th, 2026 1:59 am
AstraZeneca Breast-Cancer Drug Misses Goal in Late-Stage Trial - Sep 14th, 2026 12:02 am
ENHERTU® (fam-trastuzumab deruxtecan-nxki) demonstrated a median progression-free survival of 14.3 months as 1st-line therapy in patients with HER2-mutant advanced non-small cell lung cancer in DESTINY-Lung04 Phase III trial - Sep 13th, 2026 7:55 pm
TAGRISSO® (osimertinib) demonstrated unprecedented eight-year landmark survival in early-stage EGFR-mutated lung cancer in ADAURA Phase III trial - Sep 13th, 2026 7:47 pm
AstraZeneca COPD Drug Cuts Exacerbations as FDA Priority Review Nears - Sep 13th, 2026 4:01 am
AZN Stock Slips After-Hours Following Latest Late-Stage Oncology Trial Miss — Executive ‘Disappointed,’ Reiterates Breast Cancer Focus - Sep 11th, 2026 4:11 pm
AstraZeneca Stock Trips On Unexpected Failure In Breast Cancer - Sep 11th, 2026 3:01 pm
Jim Cramer Says He Is Not Going to Put His Money on AstraZeneca (AZN) - Sep 11th, 2026 2:02 pm